"Real World" Administration of Zepatier (Grazoprevir Plus Elvasvir) in Chronic Hemodialysis Patients With Hepatitis C Infection. Strategies for Identification of Patients, Insurance Approval, Treatment , and Laboratory Monitoring
Phase: PHASE4
Conditions: Hepatitis C, Hemodialysis, Nosocomial Infection
Sponsor: University of Pennsylvania

Protocol Title: Real World Administration of Zepatier (Grazoprevir plus Elbasvir) in 
Chronic Hemodialysis Patients with Hepatitis C Infection. Strategies 
for Identification of Candidate Hemodialysis Patients, Obtainment 
of Insurance Approval, Treatment Guidelines, and Laboratory and 
Clinical Monitoring During Therapy Directed to Nephrologists 
NCT Number: 03365635 
IRB Approval Date: August 13, 2018 
Document: Protocol August 18, 2021